Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Evidence that fibroblasts derive from epithelium during tissue fibrosis
Masayuki Iwano, … , Hirokazu Okada, Eric G. Neilson
Masayuki Iwano, … , Hirokazu Okada, Eric G. Neilson
Published August 1, 2002
Citation Information: J Clin Invest. 2002;110(3):341-350. https://doi.org/10.1172/JCI15518.
View: Text | PDF
Article Hematology

Evidence that fibroblasts derive from epithelium during tissue fibrosis

  • Text
  • PDF
Abstract

Research Article

Authors

Masayuki Iwano, David Plieth, Theodore M. Danoff, Chengsen Xue, Hirokazu Okada, Eric G. Neilson

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Fibroblast cell counts in renal tissues after UUO (8). Several different...
Fibroblast cell counts in renal tissues after UUO (8). Several different groups of kidneys were compared to determine the relative contributions of each to the source of fibroblasts. Forty to 80 random high-power fields in cortical kidneys were counted for FSP1+ fibroblasts, EMT-derived LacZ+ fibroblasts, or GFP+ fibroblasts, depending on the group. Mean fibroblast counts are represented by a horizontal line in each column: 12% of normal resident fibroblasts in the kidney come from bone marrow (number of FSP1+, GFP+ fibroblasts from normal, chimeric recipient kidneys divided by the number of FSP1+, GFP+ fibroblasts from FSP1.GFP+ donor kidneys); local EMT as a source is rare in the absence of fibrogenic stress (number of FSP1+, LacZ+ fibroblasts from normal kidneys divided by the number of FSP1+ fibroblasts from normal kidneys); and during experimental fibrosis, local EMT (number of FSP1+, LacZ+ fibroblasts from UUO kidneys divided by the number of FSP1+ fibroblasts from UUO kidneys) and bone marrow (number of FSP1+, GFP+ fibroblasts from UUO, chimeric recipient kidneys divided by the number of FSP1+ fibroblasts from UUO kidneys) contribute 36% and 15% of fibroblasts, respectively.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts